Global Trends and Scientific Impact of Topical Probiotics in Dermatological Treatment and Skincare

Ademilton Costa Alves † , Sergio Murilo da Silva Braga Martins, Jr. † , José Victor Trindade Belo, Mauro Victor Castro Lemos , Carlos Emanuel de Matos Chaves Lima, Carlos Drielson da Silva, Adrielle Zagmignan and Luís Cláudio Nascimento da Silva * 

Citation: Alves, A.C.; Martins, S.M.d.S.B., Jr.; Belo, J.V.T.; Lemos, M.V.C.; Lima, C.E.d.M.C.; Silva, C.D.d.; Zagmignan, A.; Nascimento da Silva, L.C. Global Trends and Scientific Impact of Topical Probiotics in Dermatological Treatment and Scientific Microorganisms 2024, 12, 2010. https://doi.org/10.3390/ microorganisms12102010 Academic Editor: Alex Galanis Received: 16 August 2024 Revised: 21 September 2024 Accepted: 24 September 2024 Published: 3 October 2024

Copyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/)

Laboratório de Patogenicidade Microbiana, Universidade CEUMA, São Luis 65075-120, MA, Brazil; 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 (A.C.A.); 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 (S.M.d.S.B.M.J.); 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 (J.V.T.B.); 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 (M.V.C.L.); 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 (C.E.d.M.C.L.); 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 (C.D.d.S.); 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 (A.Z.) * Correspondence: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。; Tel.: +55-(98)-9-8431-8133 † These authors contributed equally to this work.

Abstract: The skin plays a crucial role in maintaining homeostasis and protecting against external ag gressors. Recent research has highlighted the potential of probiotics and postbiotics in dermatological treatments and skincare. These beneficial microorganisms interact with the skin microbiota, modulate the immune response, and enhance the skin barrier, offering a promising therapeutic avenue for various skin conditions, such as acne, dermatitis, eczema, and psoriasis. This bibliometric study aims to analyze the global trends and scientific impact of topical probiotics in dermatology. By reviewing 106 articles published between 2013 and 2023, the study categorizes the applications of probiotics in wound healing, inflammatory skin diseases, and general skincare. The findings indicate a sig nificant increase in publications from 2021 onwards, attributed to the heightened focus on medical research during the COVID-19 pandemic. This study also identifies the most productive countries, institutions, and authors in this field, highlighting the importance of international collaborations. The results underscore the efficacy of probiotic-based topical formulations in improving skin health, reducing inflammation, and enhancing wound healing. This comprehensive analysis supports the development of new therapeutic strategies based on topical probiotics and encourages high-quality research in this promising area.

Keywords: topical probiotics; skin microbiome; wound healing; inflammatory skin diseases; skin care

Regenerative topical skincare: stem cells and exosomes

Amy Forman Taub1,2 *

1 Institute Advanced Dermatology, A Forefront Dermatology Practice, Lincolnshire, IL, United States,

2 Department of Dermatology, Institute Northwestern University Medical School, Chicago, IL, United States

OPEN ACCESS EDITED BY Saranya Wyles, Mayo Clinic, United States REVIEWED BY Alessandra Magenta, Consiglio Nazionale delle Ricerche (CNR), Italy Krishna Vyas, Massachusetts General Hospital and Harvard Medical School, United States *CORRESPONDENCE Amy Forman Taub 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 RECEIVED 04 June 2024 ACCEPTED 20 August 2024 PUBLISHED 15 October 2024 CITATION Taub AF (2024) Regenerative topical skincare: stem cells and exosomes. Front. Med. 11:1443963. doi: 10.3389/fmed.2024.1443963 COPYRIGHT

© 2024 Taub. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Regenerative medicine and its offshoot, regenerative aesthetics, have been hot topics over the past 15  years. Studies with heterochronic parabiosis and others pointed to a circulating factor that could rejuvenate aging tissues. Stem cells are known to have regenerative powers, but they are difficult to extract, grow in culture or maintain. Exosomes (EVs), extracellular vesicles from 30 to 150 nm, have been discovered to be a primary form of communication between tissues. Using stem cell supernatants to generate desirable EVs has become a heralded treatment for aesthetic treatments. Preclinical studies with EVs show many benefits including improving the function of fibroblasts and healing wounds more rapidly. Clinical studies with EVs in aesthetics are very few. Thus, the excitement generated by EVs should be tempered with realism about the lack of available treatment products as well as the lack of scientific proof.

KEYWORDS skin, aesthetic, regenerative, stem cells, exosomes

Can a 19th Century French Medical Debate Provide Guidance on How to Tackle Type 2 Diabetes?

Abdo S. Yazbeck

To cite this article: Abdo S. Yazbeck (2025) Can a 19th Century French Medical Debate Provide Guidance on How to Tackle Type 2 Diabetes?, Health Systems & Reform, 11:1, 2464977, DOI: 10.1080/23288604.2025.2464977

To link to this article: https://doi.org/10.1080/23288604.2025.2464977

© 2025 The Author(s). Published with license by Taylor & Francis Group, LLC.

Published online: 25 Feb 2025.

Submit your article to this journal

Article views: 1030

View related articles

View Crossmark data

© 2025 The Author(s). Published with license by Taylor & Francis Group, LLC.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

ARTICLE HISTORY Received 24 November 2024; Revised 1 February 2025; Accepted 5 February 2025

KEYWORDS Health systems; type 2 diabetes; non-communicable diseases; germ theory of disease

Moisturizer induced contact anaphylaxis

Bronte Jeffrey1,2*, Logan Gardner6,7, Michelle Le1 , Julie Frost1 and Ming Wei Lin1,3,4,5

*Correspondence: Bronte Jeffrey 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

1 Department of Clinical Immunology, Westmead Hospital, Sydney, Australia

2 St Vincent’s Clinical School, University of New South Wales, Sydney, Australia

3 Faculty of Medicine and Health, University of Sydney, Sydney, Australia

4 Department of Immunopathology, Westmead Hospital, Sydney, Australia

5 Centre for Immunology and Allergy Research, Westmead Institute of Medical Research, Sydney, Australia

6 Allergy, Asthma and Clinical Immunology, The Alfred Hospital, Melbourne, Australia

7 School of Public Health & Preventive Medicine, Monash University, Melbourne, Australia

© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Evaluation of Patients With Positive Patch Test Reactions to Rubber Additives: A Retrospective Study From Turkey Between 1996 and 2023

İbrahim Halil Aydoğdu | Esen Özkaya Department of Dermatology and Venereology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey

Correspondence: İbrahim Halil Aydoğdu (该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。)

Received: 26 April 2025 | Revised: 14 June 2025 | Accepted: 30 June 2025

Funding: The authors received no specific funding for this work.

Keywords: allergic contact dermatitis | carbamate | epidemiology | glove | mercapto | nonoccupational | occupational | patch test | rubber additives | thiuram

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. © 2025 The Author(s). Contact Dermatitis published by John Wiley & Sons Ltd.

ABSTRACT

Background: Rubber additives are common causes of allergic contact dermatitis (ACD) worldwide, yet data from Turkey remain

Objectives: To evaluate the prevalence of rubber additive sensitisation and its clinical/occupational relevance in a tertiary re ferral centre.

Methods: A retrospective study on 2687 consecutively patch-tested patients with rubber additives at our allergy unit between 1996 and 2023.

Results: Rubber sensitisation was found in 10.6%, with a slight increase after 2010. Male predominance was noted (female: male=1:2.3). Thiurams and carbamates were the most frequent sensitizers. ACD was diagnosed in 7.9%, primarily caused  by gloves (85.5%). Hands were most commonly affected (94.4%). Logistic regression analysis showed that thiuram and carba mate sensitisation was significantly associated with hand eczema, while benzothiazole derivatives were linked to foot eczema. Airborne ACD occurred in 4.2%, mainly in healthcare workers. Hand eczema with and without wrist extension was observed with similar frequency. Occupational ACD accounted for 79.3% of cases, especially among construction (56.8%) and healthcare workers (14.8%), with a relative increase in the latter group after 2015.

Conclusions: The high prevalence of sensitisation from rubber gloves is concerning. Legal measures are urgently needed, includ ing safer additives and clearer glove labelling. Patch testing remains essential, even without the classic glove-pattern distribution.

European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice

Jeanne D. Johansen1, Kristiina Aalto-Korte2, Tove Agner3, Klaus E. Andersen4, Andreas Bircher5, Magnus Bruze6, Alicia Cannavó7, Ana Giménez-Arnau8, Margarida Gonçalo9, An Goossens10, Swen M. John11, Carola Lidén12, Magnus Lindberg13, Vera Mahler14, Mihály Matura15, Thomas Rustemeyer16, Jørgen Serup3, Radoslaw Spiewak17, Jacob P. Thyssen1, Martine Vigan18, Ian R. White19, Mark Wilkinson20 and Wolfgang Uter21

1 Department of Dermato-Allergology, National Allergy Research Centre, Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark,

2 Occupational Medicine, Finnish Institute of Occupational Health, 00250 Helsinki, Finland, 3Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, 2400 Copenhagen, Denmark, 4Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, 5000 Odense, Denmark, 5Allergy Unit, Department of Dermatology, University Hospital and University of Basel, 4031 Basel, Switzerland, 6Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, SE-20502 Malmö, Sweden, 7Hospital Municipal de Vicente López ‘Profesor Bernard Houssay’, Buenos Aires, Argentina, 8Department of Dermatology, Hospital del Mar, Universitat Autónoma de Barcelona, 08003 Barcelona, Spain, 9Department of Dermatology, University Hospital and Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal, 10Contact Allergy Unit, Department of Dermatology, University Hospital K. U. Leuven, B-3000 Leuven, Belgium, 11Department of Dermatology, Environmental Medicine, Health Theory, University of Osnabrueck, D-49069 Osnabrueck, Germany, 12Institute of Environmental Medicine, Karolinska Institutet, SE-17177 Stockholm, Sweden, 13Department of Dermatology, University Hospital Örebro, SE-70185 Örebro, Sweden, 14Allergy Unit, Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany, 15Unit of Occupational and Environmental Dermatology, Centre for Occupational and Environmental Medicine, SLSO, SE-11365 Stockholm, Sweden, 16Department of Dermatology, VU University Medical Centre, 1081 HV Amsterdam, The Netherlands, 17Department of Experimental Dermatology and Cosmetology, Jagiellonian University Medical College, 30-688 Krakow, Poland, 18Department of Dermatology, CHRU Besançon, 25030 Besançon Cedex, France, 19Department of Cutaneous Allergy, St John’s Institute of Dermatology, St Thomas’ Hospital, London, SE1 7EH UK, 20Spire Hospital, Leeds, LS8 1NT UK, and 21Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen/Nürnberg, 91054 Erlangen, Germany doi:10.1111/cod.12432 Correspondence: Jeanne D. Johansen, Department of Dermato-allergology, Gentofte Hospital, 2900 Hellerup, Denmark. Tel: +4538677301. E-mail: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 Conflicts of interests: KAK, JDJ, AC, CL, ML, MM, JS, IRW: No conflicts. TA: Giving talks at meetings arranged by Leo Pharma and GlaxoSmithKline; KEA: Advisor to SmartPractice, Hillerød. Medical Director for Dermatological Investigation (DIS). Research support from IFRA and RIFM; AB: Educational grants from Novartis, GSK, Vifor; MB: member of the REXPAN, collaboration with SmartPractice on metal allergens; AGA: Medical Advisor for Uriach Pharma, Genentech, Novartis research grants by Intendis – Bayer, Uriach Pharma, Novartis, educational activities sponsored by Uriach Pharma, Novartis, Genentech, Menarini, GSK, MSD, Almirall; MG: Participated in the EDEN study on fragrance allergy. Since January 2014 participatation in the National Advisory Board for NOVARTIS (omalizumab for urticaria). Lectures on immunology of psoriasis for Portuguese dermatologists paid by Janssen (2012/13); AG: Departmental service (contact allergy website) financially supported by cosmetic and a few pharmaceutical companies; lecture on allergic contact dermatitis from cosmetics for GSK; lectures to pharmacists and dermatologists on dermatological preparations (contact allergy, irritancy) for Fagron; SMJ: Lecture fees from Almirall, Biogen-Idec, Galderma; VM: Has received lecturing fees from SmartPractice, Almirall Hermal, GlaxoSmithKline, Basilea; TR: Grants for the department from Almirall, Novartis, Zilverlon, Stallergenes; RS: Shareholder and scientific adviser of the Polish representative of Chemotechnique Diagnostics; JPT: Sold a cobalt spot test to Smart Health, Az, USA; MV: Grants from GlaxoSmithKline, Unilever, l’ARCAA; MW: Attended a drug advisory board meeting for GlaxoSmithKline; WU: Accepted travel reimbursement and partly honorarium for presentations given to cosmetic industry (associations) by them. Lecture fee from Almirall Hermal for educational lectures on contact allergy. Accepted for publication 6 May 2015

Summary

The present guideline summarizes all aspects of patch testing for the diagnosis of contact allergy in patients suspected of suffering, or having been suffering, from allergic contact dermatitis or other delayed-type hypersensitivity skin and mucosal conditions. Sections with brief descriptions and discussions of different pertinent topics are followed by a highlighted short practical recommendation. Topics comprise, after an introduction with important definitions, materials, technique, modifications of epicutaneous testing, indi vidual factors influencing the patch test outcome or necessitating special considerations, children, patients with occupational contact dermatitis and drug eruptions as special groups, patch testing of materials brought in by the patient, adverse effects of patch testing, and the final evaluation and patient counselling based on this judgement. Finally, short reference is made to aspects of (continuing) medical education and to electronic collection of data for epidemiological surveillance.

Key words: contact allergy; guideline; patch testing; review.